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EFFECT OF EXPERIMENTAL CHOLESTASIS ON
NEUROMUSCULAR BLOCKING DRUGS IN CATS
P. WESTRA, M. C. HOUWERTJES, A. R. DE LANGE, A. H. J. SCAF, F. R. HINDRIKS AND S. AGOSTON
SUMMARY
Pancuronium, Org 6368 and gallamine were compared in control cats and in cats with experimental
cholestasis. A decrease in the plasma clearance and a prolongation of neuromuscular blockade with
Org 6368 and pancuronium were found in the latter; no significant difference was detected in the
biotransformation pattern of Org 6368 and pancuronium compared with controls. Inhibition of
hepatic uptake of Org 6368 and pancuronium in extrahepatic cholestasis might explain the significant
alterations in the pharmacokinetics of the two steroid neuromuscular blocking drugs. The phanna-
cokinetics of gallRmine were normal during cholestasis. The results suggest that, under pathological
conditions involving increased plasma concentrations of bile salts, neuromuscular blocking agents
that are cleared from the plasma by the liver may have an impaired hepatic uptake and consequently
a prolonged duration of action.
Cholestasis is associated with a variety of metabolic
abnormalities some of which, for example jaundice
and increased plasma bile salt concentrations with
steatorrhea, are the direct result of the failure of
bilirubin and bile salt secretion into bile. However,
certain other phenomena associated with extra-
hepatic cholestasis are more difficult to explain.
Examples are the increased duration of action of
hexobarbitone in rabbits with obstructive jaundice
(McLuen and Fouts, 1961) and a prolongation of the
sleeping time caused by the steroid anaesthetic
Althesin (Novelli, Marsili and Lorenzi, 1975). Ward,
Adu-Gyamfi and Strunin (1975) reported difficulties
in antagonizing the effects of pancuronium in two
patients with severe obstructive jaundice. Significant
changes in the elimination of pancuronium which
resulted in a prolonged neuromuscular blockade in
patients with total biliary obstruction, were reported
by Somogyi, Shanks and Triggs (1977).
The liver takes up many drugs from the blood-
stream and plays an important role in the metabolism
and excretion of these compounds. Interference with
P. WESTRA, DRS.; A. R. DE LANGE; S. AGOSTON, M.D.,
PH.D.; Research Group of Anaesthesiology and Clinical
Pharmacology of the Medical Faculty, State University of
Groningen, Bloemsingel 1, 9713 BZ Groningen, The
Netherlands. A. H. J. SCAF, PH.D.; M. C. HOUWERTJES;
Department of Pharmacology and Clinical Pharmacology,
State University of Groningen. F. R. HINDRIKS, PH.D.,
Central Laboratory for Clinical Chemistry, University
Hospital Groningen.
Correspondence to P. Westra.
0007-0912/80/080747-11 $01.00
either of these processes will affect the pharmaco-
kinetic pattern of such drugs. This may have clinical
consequences such as alterations in their duration of
action.
In the case of the neuromuscular blocking drugs
tubocurarine (Cohen, Brewer and Smith, 1967;
Meijer and Scaf, 1968; Meijer et al., 1979), pan-
curonium (Agoston et al., 1973; Buzello, 1975) and
hexafluorenium (Meijer, Vermeer and Kwant, 1971),
hepatic uptake and secretion appear to be major factors
in determining the plasma concentrations. In the
cat, hepatic uptake is an important factor in the
plasma clearance of a number of steroid neuro-
muscular blocking agents, such as pancuronium,
dacuronium and Org 6368 (Agoston, Kersten and
Meijer, 1973; Agoston et al., 1977).
We investigated the fate of non-depolarizing
neuromuscular blocking agents in extrahepatic
cholestasis. Three compounds, known to differ
considerably in their elimination pathways (i.e. renal
or biliary), were studied:
Org 6368, the bisquaternary ammonium compound
(2£,16$,-dipiperidino-5a-androstan-3a-ol acetate di-
methobromide) differing from pancuronium only in
lacking the acetate group at C17 position in the
steroid skeleton and having a short duration of action
in the cat (Sugrue and Duff, 1973), mainly as a result
of a rapid hepatic uptake (Agoston et al., 1977);
gallamine triethiodide, which in dog and man is pre-
dominantly eliminated by the kidneys (Mushin et al.,
1949; Feldman, Cohen and Golling, 1969; Agoston
et al., 1978);
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pancuromum, which in cat and man is eliminated by
both urinary and binary routes (Agoston, Kersten
and Meijer, 1973; Agoston et al., 1973).
The dynamics and kinetics of these compounds
were investigated in cats with experimentally induced
cholestasis and compared with control animals.
MATERIALS AND METHODS
Operative procedures
Ligation of the bile duct was performed under
anaesthesia with sodium pentobarbitone anaesthesia
(40 mg kg"1 i.p.), or 2% halodiane in 33% oxygen
in nitrous oxide after kctamine 50-100 mg i.m. An
endotracheal tube was inserted and the lungs
ventilated artificially. A mid-line abdominal incision
was made, and the common bile duct was doubly
ligated with Perma-Hand Seide 4-0 suture approxi-
mately 1 cm from the point of entry to the duodenum.
The cystic duct was doubly ligated at the base of the
gall-bladder, after which the incision was closed with
Perma-Hand Seide. The entire operation took less
than 30 min. After the operation, all animals were
treated with ampicillin 100-200 mg, i.m. The
obstruction of the bile ducts lasted 9-10 days. Sham-
operated (all manipulations without ligation) and
un-manipulated cats served as controls.
Animal experiments
All experiments were carried out in adult cats
(2.8 ± 0.2 kg) of either sex under pentobarbitone
anaesthesia (40 mg kg-1, i.p. plus maintenance doses
of 4 mg kg"1 i.v.). After orotracheal intubation,
artificial ventilation with air through a cuffed Magill
tube of 5.5 mm external diameter was maintained
with a Braun respirator type 1955, set at a rate of
30 b.p.m. and a tidal volume of 10 ml kg-1. A
polythene cannula was introduced into the common
bile duct and in the control animals the cystic duct
was ligated. Through a low abdominal incision, the
urethra and the urinary bladder were visualized and
the urethra was cannulated. In order to check the
general condition of the cat, e.c.g. (ECG-Pulse
Monitor, MS-35; Electrodyne Co. Inc., U.S.A.)
and mean arterial pressure (Statham P23D6-trans-
ducer; KWS 3085 HSE Electro-Manometer) were
monitored. Body temperature was kept constant at
36-38 °C by heating the operating table. Rectal
temperature was measured with a thermistor (Electro-
laboriet, Copenhagen). To replace fluid loss, glucose
(2.5%) and saline (0.45%) were infused through a
polythene cannula in the external jugular vein.
Neuromuscular studies (isometric twitch tension)
were performed on the tibialis anterior muscle which
was stimulated through the common peroneal nerve
with supramaximal square-wave pulses of 0.2-ms
duration at a frequency of 0.1 Hz. The stimulus was
supplied from a Grass S88 stimulator and SIU 5
stimulus isolation unit. The tendon of the tibialis
anterior muscle was connected to a load cell (UL4-20,
Statham), attached to a force-displacement transducer
(UC3 Gold Cell, Statham), mounted securely on a
Braun-Schuster myograph. The signal was amplified
by a Hottinger-Baldwin amplifier (Messtechniek,
Darmstadt) and muscle contractions were continuously
recorded on a MFE two-channel polygraph (d.c. to
40 Hz, full scale). Pancuronium 0.3 mg kg"1, Org
6368 l.Smgkg-1 and gallamine S.Omgkg-1 were
injected i.v. over 5 s. Blood, urine and bile samples
were collected at fixed intervals. Eight hours after
administration of the drugs, the experiments were
terminated by removing the liver within 2 min All
samples were deep frozen for later chemical analysis.
Neuromuscular studies
The time to the onset of maximum block was
defined as the time which elapsed from the injection
until the twitch had reached its minimum value. For
the duration of action, two indices were used:
(a) time from administration of the drug until the
return of the twitch tension to 50% of control
value (duration 50);
(b) time from administration of the drug until
. reversal to 90% of control tension (duration 90).
Recovery time is defined as the time from the
minimum value before recovery to 25, 50 and 75%
recovery of control twitch tension (recovery 25, 50,
75). The recovery rate is the time from 25 to 75%
recovery of control twitch tension (recovery rate
25-75) (fig. 1).
Analysis of the quaternary ammonium compounds and
of some physiological plasma constituents
Determinations of plasma concentrations of total
bilirubin, direct bilirubin, total cholesterol, glutamic-
pyruvic transaminase, alkaline phosphatase, urea and
creatinine of the cats were performed with an
Automatic Chemical Analyzer of E. I. du Pont de
Nemours & Co. (Inc.), Wilmington, DE 19898.
Enzyme activities are expressed in international units
per litre (iu litre-1).
Total bile salt concentrations in the plasma were
measured with an enzymatic kit for spectrofluori-
metric end-point determinations (Sterognost-3a
Automated, Nyegaard & Co. AS, Oslo, Norway).
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Duration Recovery
Onset
FIG. 1. Characterization of the neuromuscular blockade.
3a-Hydroxysteroid dehydrogenase transforms the
3<x-hydroxyl group on steroids of the C19, C21 and
C24 series into their corresponding keto forms, by
which NADH is generated from NAD (Mashige,
Imai and Osuga, 1976; Osuga et al., 1977). The
reduction equivalents of NADH are transferred to
the fluorogen resazurin by the enzyme diaphorase,
with formation of the fluorophore resorufin. This
substance is measured with an Aminco-Bowman
Spectrofluorimeter (Am. Instr. Comp.). Excitation
wave length was 565 nm and emission wave length
580 nm.
Spectrofluorimetric determinations of pancuronium
Org 6368 and gallamine and thin-layer chromato-
graphy of these bis(tris)-quaternary ammonium
compounds and metabolites have been described in
detail elsewhere (Kersten, Meijer and Agoston,
1973; Agoston et al., 1977; Agoston et al., 1978).
The fluorimetric method for bisquaternary
ammonium compounds does not discriminate be-
tween pancuronium, Org 6368 and their deacetylated
metabolites(s). Chromatographic quantification of the
bisquaternary ammonium compounds in bile and
liver homogenate as described previously (Kersten,
Meijer and Agoston, 1973; Agoston et al., 1977) was
improved by mixing the samples (1 ml) with 0.1 ml
of a saturated copper sulphate solution and removing
the precipitated material by centrifugation. The
supernatant was used for further chromatographic
procedures.
Conjugation
To investigate a possible conjugation of Org 6368
or metabolite(s) with sulphate or glucuronic acid
liver homogenates of control cats receiving Org 6368
1.5 mg kg"1 were analysed.
Sulphate conjugation: to 2 ml of liver homogenate
(1 mg of tissue in 1 ml Krebs-bicarbonate) 1 ml of
Tris-buffer 2 mol litre-1 (pH = 7.4) and 100 (jJitre
partially purified bacterial aryl sulphatase solution
(Sigma, St Louis, U.S.A.) were added.
Glucuromdation: to 2 nil of liver homogenate, 1 ml
of sodium acetate-buffer 0.5 mol litre"1 (pH = 6.0)
and 100 (Jitre of highly purified bacterial glucuroni-
dase solution (Boehringer, Mannheim, West
Germany) were added. The mixtures were adjusted
to 15 ml with distilled water and incubated for 2.5 h
at 37 °C. The same liver homogenates without
addition of the enzyme preparations served as
controls. Fluorescence of non-enzyme treated and
enzyme-treated livers containing Org 6368 or its
metabolite(s) were compared. This method is based
on the assumption that the polar conjugates of the
metabolites) of Org 6368 will not be extracted with
Rose-Bengal into the chloroform phase (Buzello,
1975).
Statistics
All values are given as mean + SEM. Statistical
significance was tested using either the paired or the
unpaired Student's t test with a 95% significance
level.
Pharmacokinetic calculations
The disposition of neuromuscular blocking drugs
can be described mathematically by a two- or three-
compartment open model (Gibaldi, Levy and
Hayton, 1972; McLeod, Watson and Rawlins, 1975;
Somogyi, Shanks and Triggs, 1976, Miller et al.,
1979).
Plasma clearance curves were fitted using a
computerized program which, after balanced iterative
peeling of the curves, yields straight regression lines
of log plasma concentration v. time, using the least
squares method. Pharmacokinetic model-parameters,
such as steady-state volume of distribution (F**),
volume of central compartment (VJ and plasma




There was no impairment of renal glomerular
filtration in the cats with extrahepatic cholestasis,
as judged by normal plasma concentrations of
creatinine and urea. The liver function tests revealed
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significant increases of the enzymes alkaline phospha-
tase (AP) and glutamic-pyruvic transaminase (GPT)
in the jaundiced cats. Significant increases in the
plasma concentrations of total cholesterol and total
bilirubin were observed. Approximately 60% of the
total bilirubin in the plasma was present as a
glucuronide conjugate.
Total bile salt concentrations in plasma, after 9-10
days experimental cholestasis, were increased more
than 100-fold as compared with control. Relief of
biliary obstruction by cannulation of the common
bile duct caused a linear decay of the plasma bile salt
concentration, indicating saturation elimination
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FIG. 2. Total bile salt concentration in plasma after relief of
the biliary obstruction (n = 12). Mean±SEM.
the initial value (fig. 2). Total cholesterol concentra-
tions had returned to baseline after 480 min and total
bilirubin plasma concentration was decreased by
about 40% at that time (table I).
Pharmacodynamics
The phannacodynamic indices defining the neuro-
muscular blockade of Org 6368 in cats with experi-
mental chok-stasis differed clearly from those of the
control animals, except for the time of onset of
action. The same is true, but to a lesser extent, for
pancuronium (table II).
Cholestasis produced a 5.5-fold prolongation of the
duration to 90% twitch recovery with Org 6368
compared with controls; for pancuronium this
prolongation was only 1.6-fold (fig. 3). In contrast,
ORG 6368 PANCURONIUM GALLAMINE
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FIG. 3. Duration to 50 and 90% recovery of control twitch
tension and the recovery rate from 25 to 75% of control
twitch tension for Org 6368, pancuronium and gallamine in
control cats and cats with cholestasis. Mean ± SEM.
* Significant difference from control.
cholestasis had no influence on the dynamics of
gallamine (table II). Also, no significant differences
between un-manipulated control cats and sham-
operated cats were found for Org 6368 in this respect
(table II).
Pharmacokinetics of Org 6368
The pharmacokinetic indices such as the half-lives
(7V1, 7 / and 7V/), the plasma clearance (C/), the
volume of central compartment (Vx) and the steady-
state volume of distribution (l^*) of the three
quaternary ammonium compounds are given in
table IV. For Org 6368, a considerable decrease in
plasma clearance and significant increases of the
distribution half-life 7V* and of the elimination half-
life Tf were found in extrahepatic cholestasis (table
IV, fig. 4).
The cumulative urinary excretion of Org 6368
(fig. 5) in extrahepatic cholestasis revealed a profound
increase, from 10% to approximately 40% of the























































































TABLE II. Quantification of neuromuscular blockade after i.v. administration of Org 6368, pancuronium and gallamine in control cats, sham-operated cats (only
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FIG. 4. Semilogarithmic plot of the mean plasma con-
centration-time profiles of Org 6368 in control cats (n = 5)








FIG. 5. Cumulative urinary and biliary excretion of Org
6368 and its metabolite in control cats (n = 5) and cats with





FIG. 6. Semilogarithmic plot of the mean plasma concentra-
tion-time profiles of pancuronfum in control cats (n = 5)






FIG. 7. Cumulative urinary and biliary excretion of pan-
curonium and its metabolites in control cats (n = 5) and
cats with cholestasis (n = 4). Mean ± SEM. * Significantly
difference from controls.
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administered dose, compared with the control cats.
No statistically significant differences were found for
the biliary excretion and the liver content after 8 h
for Org 6368 between extrahepatic cholestasis and
the control cats (fig. 5, table III). The total recovery
of Org 6368 from bile, urine and liver in extrahepatic
cholestasis was significantly greater than in the
control cats (table III). There were no statistical
differences in kinetics between the un-manipulated
control cats and the sham-operated cats for Org 6368
(tables III, IV).
Pharmacokinetics of pancuronium
The elimination half-life Tf for pancuronium in
extrahepatic cholestasis differed from that in the
control cats (table IV, fig. 6).
Cumulative urinary excretion of pancuronium
showed a 1.8-fold increase compared with control
(fig. 7).
Pancuronium could not be detected in the bile of
cats with cholestasis (fig. 7), while the liver content of
pancuronium after 8 h was significantly less than in
controls (table III). The total recovery from bile,
urine and liver of pancuronium in extrahepatic
cholestasis was significantly greater than in the
control (table III).
Pharmacokinetics of gallamine
The pharmacokinetics for gallamine did not show
significant differences between the group of cats with
extrahepatic cholestasis and the control (tables III,
IV, figs 8, 9).
Biotransformation
Thin-layer chromatography of urine, bile and
liver samples of cats receiving Org 6368 was per-
formed to obtain more information on biotrans-
formation in extrahepatic cholestasis.
We found that, in extrahepatic cholestasis, Org
6368 is metabolized to its 3-hydroxy derivative to
about the same extent as in control cats—approxi-
mately 60% of the administered dose after 8 h
TABLE I I I . 77K mean percentage of the dose of neuromuscular blocking drug in the hver, bile and urine 8 h after i.v.
administration of pancuronium, Org 6368 and gallamine in control cats, sham-operated cats (only in case of Org 6368)
and cats with cholestasis. * Figures in parentheses indicate the approximate percentage of the compounds which are
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Org 6368 and gallamine in control cats, sham-
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FIG. 8. Semilogarithmic plot of the mean concentration-
time profiles of gallamine in control cats (n = 5) and cats with
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Time (h)
FIG. 9. Cumulative urinary excretion of gallamine in control
cats (n = 5) and cats with cholestasis (n = 5). Mean ± SEM.
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(table III). At the end of the observation period, the
livers in both groups contained virtually the
3-hydroxy derivative alone. The metabolism of
pancuronium to its hydroxy-derivatives showed a
pattern comparable to Org 6368 (table III).
The fluorimetric yields of livers after enzymatic pre-
treatment with jS-glucuronidase and aryl-sulphatase
did not differ significantly from that of non-enzyme
treated livers.
DISCUSSION
The decrease in the plasma clearance and the con-
comitant prolongation of action of Org 6368 and
pancuronium in cats with cholestasis may have
several causes.
(a) A decrease in renal clearance. The physico-
chemical properties of the bis(tris)-quaternary
neuromuscular blocking drugs such as their
relatively low lipid solubility and moderate protein
binding (Meijer and Weitering, 1970; Waser, 1973;
Meijer, Weitering and Vonk, 1976; Meijer et al.,
1979) explain why renal elimination of such bis(tris)-
quaternary drugs occurs by glomerular filtration
(Cohen, Brewer and Smith, 1967; Raaflaub and Frey,
1972). However, renal failure as a cause of the
marked decrease in the plasma clearance of the muscle
relaxants Org 6368 and pancuronium in extrahepatic
cholestasis observed in the present study is not very
likely since renal function tests indicate a normal
glomerular filtration rate. This conclusion is support-
ed by the finding of normal kinetics of gallamine in
the cats with cholestasis.
(b) A decrease in metabolism. Duvaldestin and
colleagues (1978) investigated the fate of pan-
curonium in patients with liver cirrhosis and
reported a decrease in the biotransformation of
pancuronium to its 3-deacetylated metabolite.
Possibly, plasma cholinesterase plays a role in the
breakdown of the acetylated steroid compounds and
this enzyme is synthetized by the liver (Kalow, 1959;
Schuh, 1977). Biotransformation patterns of Org 6368
and pancuronium in cats with and without chole-
stasis in the present study were very similar. A
similar result was found for pancuronium in man
(Somogyi et al., 1977).
(c) A decrease in biliary excretion. The marked
decrease in biliary output of pancuronium and Org
6368 in extrahepatic cholestasis cannot explain the
pharmacological behaviour, since biliary excretion in
control animals was small for both compounds. The
biliary output of gallamine in extrahepatic cholestasis
was not significantly different from control.
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(d) A decrease in hepatic uptake. Inhibition of this
process might explain the decreased plasma clearance
of Org 6368 and pancuronium. The following
observations point to a" decreased hepatic uptake: the
significant decrease in the liver content of pan-
curonium after 8 h in extrahepatic cholestasis, and
the marked decrease in liver to plasma partition ratio
for Org 6368.
The data and observations presented here support
the concept that cholestasis causes an impairment of
the hepatic transport at the uptake level. The
mechanism of this effect could be an interaction of
the steroid neuromuscular blocking drugs with
naturally occurring bile components, most likely
bile salts. Several authors reported impairment of
biotransformation of drugs during extrahepatic
cholestasis, caused by increased concentrations of
bile salts (McLuen and Fouts, 1961; Hutterer et al.,
1970). Vonk and others (1978a, b) observed that bile
salts at concentrations of about 100 (xmol litre"1 and
greater inhibit hepatocellular uptake of the organic
cations tubocurarine and acetyl-procainamide ethc-
bromide in intact rats, isolated rat livers and isolated
hepatocytes. Recently, we have shown a prolongation
of the duration of action of Org 6368 by bile salts as
a result of inhibition of primary hepatic uptake
(Vonk et al., 1979). The present investigations show
that the concentrations of bile salt in plasma after
9-10 days cholestasis were increased from the normal
value of 2 (xmol litre"1 to 500 ysnol litre"1. According
to previous studies these increased concentrations
could very well account for the impaired hepatic
uptake of the bisquaternary steroidal agents.
There is no simple explanation for the greater
total recovery of Org 6368 and pancuronium and
their metabolite(s) in extrahepatic cholestasis. Forma-
tion of conjugates with sulphuric or glucuronic acid,
or both, could be excluded. Similar findings were
obtained (Buzello, 1975) for pancuronium in man.
It is possible that changes in distribution in hepatic
or extrahepatic tissues, or both, occurred.
The present results confirm the study of Somogyi,
Shanks and Triggs (1977) that the use of pancuro-
nium and other steroid neuromuscular blocking drugs
in the commonly used dosage regime in patients with
extrahepatic cholestasis may cause unexpected pro-
longation of action.
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EFFET D'UNE CHOLESTASE EXPERIMENTALE
SUR LES AGENTS DE BLOCAGE
NEUROMUSCULAIRE CHEZ LES CHATS
RESUME
On a compari le pancuronium, Org 6368 et la gnHnmin^ sur
des chats temoins et sur des chats ayant une cholestase
experimentale. On a constate sur ces derniers une diminu-
tion du coefficient d'epuration plasmatique, ainsi qu'une
prolongation du blocage neuromusculaire avec Org 6368
et le pancuronium; alors qu'aucune difference importante
n'a etc ddcelie dam le modele de biotransformation d'Org
6368 et du pancuronium par rapport aux temoins. L'inhibi-
tion de la fixation hipatique d'Org 6368 et du pancuronium
dans une cholestase extra-hepatique peut expliquer les
modifications importantes survenues dans la pharmaco-
cinetique des deux agents de blocage neuromusculaire
stiroldes. La pharmacocinetique de la gallamine a etc
normale pendant la cholestase. Les resultats laissent penser
que dans des conditions pathologiques mettant en cause
des concentrations plus fortes de sels binaries dans le
plasma, les agents de blocage neuromusculaire qui sont
degages du plasma par le foie peuvent avoir une fixation





Pancuronium, Org 6368 und Gallamin wurden verglichen—
in einer Kontrollgruppe von Katzen, und bei Katzen mit
experimenteller Cholestase. In letzterer Gruppe wurde eine
sinkende Plasmaklfirung und eine Verlangerung der
neuromuskularen Blockierung bei Org 6368 und Pancuro-
nium festgestellt; der Ablauf der Biotransformation dieser
Drogen unterschied sich auch nicht von dem in der
Kontrollgruppe. Die Unterdruckung der Leberaufnahme
dieser beiden Drogen bei extrahepatischer Cholestase
konnte die wesentlichen pharmakokinetischen Veranderun-
gen der beiden Steroiddrogen erklaren. Die pharmako-
kinetischen Vorgange von Gallamin waren wShrend
Cholcstase normal. Die Resultate zeigen, dass unter
pathologischen Bedingungen—erhOhte Plasmakonzentra-
tionen von Gallensalzen—neuromuskulare Blockierungs-
mittel, die von der Leber aus dem Plasma geklart werden,
nicht so Ieicht von der Leber aufgenommen werden kOnnen
und daher eine langere Wirkungsdauer haben konnen.
EFECTO DE LAS DROGAS DE BLOQUEO
NEUROMUSCULAR EN GATOS CON
COLESTASIS EXPERIMENTAL
SUMARIO
Se compararon pancuronium, Org 6368 y gnllamina en
gatos de control y en gatos con colestasis experimental. En
estos ultimos se apreci6, usando Org 6368 y pancuronium,
una disminucion en eliminadon de plasma y una pro-
longation del bloqueo neuromuscular. No se detecto
diferencia significativa algiina en el modelo de biotrans-
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formaci6n del Org 6368 ni en el del pancuronium, en
comparaci6n con el de lew gatos de control. La inhibition de
•bsorti6n hepatica de Org 6368 y de pancuronium en
colestasis extrahepatica puede que ezplique la significativa
•herati6n en las farmacocineticai de las dos drogas esteroides
de bloqueo neuromusculai. Las farmacotineticas de la
gallaminn fucron normales durante la colestasis. Los
resultados sugieren que, bajo conditiones patologicas en
las que acontezcan mayorcs concentraciones de sales
biliarcs en el plasma, los agentes de bloqueo neuro-
muscular que el higado eztrae del plasma, pueden sufrir
una absorti6n hepatica perjudicial y, por consiguiente,
una action de duration prolongada.
